GENEVIEVE DARWICHE: Open Payments
NPI 1821654260 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 7 companies in 2025. Trend: 2023 $248 · 2024 $411 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| PFIZER INC. | 2 | $35 |
| ABBVIE INC. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: TRINTELLIX, NURTEC ODT, VRAYLAR, ZENPEP, XIFAXAN, Wegovy, Veozah.
Industry payments across OK — which companies pay providers there.
